Theranostics Global Market Report 2024: Market Projected to Reach $164.38 Billion by 2028, Driven by Advances in Cancer Treatment and Precision Medicine
25 janv. 2024 09h36 HE
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Theranostics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global theranostics market forecast reveals...
Global Genomic Collaboration and Licensing Agreements Analysis Report 2023: Access to Upfront, Milestone, Royalties Data, Broken Down by Company A-Z, Deal Type and Therapy Area
17 nov. 2023 06h58 HE
|
Research and Markets
Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The "Genomic Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive...
Radiopharmaceutical Theranostics Market Projected to Reach $3.44 Billion by 2028, Fueled by Growing Cancer Incidence and Personalized Medicine
18 sept. 2023 07h48 HE
|
Research and Markets
Dublin, Sept. 18, 2023 (GLOBE NEWSWIRE) -- The "Radiopharmaceutical Theranostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Radioisotope, Source, Application,...
ITM Appoints Roger Estafanos as U.S. General Manager and Expands Presence with Opening of U.S. Headquarters in Princeton, New Jersey
17 avr. 2023 08h03 HE
|
ITM Isotope Technologies Munich SE
Garching / Munich and Princeton, NJ, April 17, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical theranostics company, today announced that the company has opened its U.S....
Radiopharmaceutical Theranostics Market Size to Cross USD 12.4 Bn by 2031 | Transparency Market Research
03 avr. 2023 17h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, April 04, 2023 (GLOBE NEWSWIRE) -- The global radiopharmaceutical theranostics market was valued at USD 3.0 Bn in 2022 and is projected to reach USD 12.4 Bn by...
Radiopharmaceutical Theranostics Market Worth $3.44 Billion, Globally, by 2028 at 11.3% CAGR | The Insight Partners
29 mars 2023 10h15 HE
|
The Insight Partners
Pune, India, March 29, 2023 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on "Radiopharmaceutical Theranostics Market Size, Share, Revenue, Growth Strategy, Industry...
ITM to Present Phase III COMPOSE Poster and Host Satellite Symposium on Radiotheranostics in NET cancer at ENETS Conference
16 mars 2023 09h48 HE
|
ITM Isotope Technologies Munich SE
Garching / Munich, March 16, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical theranostics company, today announced that the company will present an overview of genetic...
ITM and BAMF Health Enter Global Cooperation Agreement for Targeted Radiopharmaceuticals in U.S. Radiopharmacy and Clinic Network
08 sept. 2022 05h00 HE
|
ITM Isotope Technologies Munich SE
Garching / Munich, Germany, and Grand Rapids, MI, U.S., September 08, 2022 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and BAMF (Bold Advanced Medical...
Global Genomics Partnering Deal Terms and Agreements Report/Directory 2022: Access to 900+ Deals Entered into by the World's Leading Healthcare Companies
05 sept. 2022 06h58 HE
|
Research and Markets
Dublin, Sept. 05, 2022 (GLOBE NEWSWIRE) -- The "Global Genomics Partnering Terms and Agreements 2015 to 2022" report has been added to ResearchAndMarkets.com's offering.Access to 900+ Genomics...
ITM Acquires a New Platform for the Development of Next-Generation Theranostics
18 août 2022 05h18 HE
|
ITM Isotope Technologies Munich SE
• Technology platform for PET tracers strengthens ITM’s radiodiagnostic portfolio • Additional assets potentially expand ITM’s pipeline of novel targeted radionuclide therapeutics Garching /...